Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation.

Mulder, Jorn; van Rossum, Tobias; Mariz, Segundo; Magrelli, Armando; de Boer, Anthonius; Pasmooij, Anna M G; Stoyanova-Beninska, Violeta.

Afiliação

Mulder J; Medicines Evaluation Board, Utrecht, Netherlands.
van Rossum T; Medicines Evaluation Board, Utrecht, Netherlands.
Mariz S; European Medicines Agency, Amsterdam, Netherlands.
Magrelli A; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
de Boer A; Medicines Evaluation Board, Utrecht, Netherlands.
Pasmooij AMG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, Netherlands.
Stoyanova-Beninska V; Medicines Evaluation Board, Utrecht, Netherlands.

Front Oncol ; 11: 809035, 2021.

Article em En | MEDLINE | ID: mdl-34988030